Acceleron Pharma
XLRN
#1924
Rank
S$13.83 B
Marketcap
S$226.23
Share price
0.00%
Change (1 day)
14,254.15%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: S$13.83 Billion

As of February 2026 Acceleron Pharma has a market cap of S$13.83 Billion. This makes Acceleron Pharma the world's 1924th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022S$14.65 B-0.84%
2021S$14.77 B44.92%
2020S$10.19 B168.56%
2019S$3.79 B37.97%
2018S$2.75 B7.19%
2017S$2.56 B84.17%
2016S$1.39 B-39.32%
2015S$2.29 B37.62%
2014S$1.66 B17.38%
2013S$1.42 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$739.58 B 5,245.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$191.76 B 1,286.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$255.67 B 1,748.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$104.31 B 654.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.18 B-98.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S$26.45 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
S$61.59 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA